FIP is a dreadful disease and Belle Ayr has been working with Dr Diane Addie, one of the leading researchers in the subject, in investigating possible causes and treatments of it.

This study provides a useful model for differentiating recovery from chronic coronavirus disease using acute phase protein monitoring.

Dr. Diane Addie, et al, have published a paper on the efficacy of using MutianX to stop the shedding of the FCoV virus.

Belle Ayr was pleased to provide the funding that enabled the publication of this research.